MDT stock price:$108.12-0.36%At close on October 18th, 2019
Updated on: October 18th, 2019
5
Medtronic depreciated an unpleasant -0.36% and closed at $108.12.
Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide.
Should I buy Medtronic stock?
Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor.That's why is so important to define your own trading plan that matches with your character as inversor.There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Medtronic stock doesn't match any of these trading strategies, so our recommendation is not to buy.
Buy setup
Elegible
New all-time high
No
New 52 week high
No
Price crossing up 200d MA
No
100d MA crossing up 200d MA
No
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.
Is Medtronic stock a buy?
Financial institutions and banks post stock ratings everyday.
At Stocks2.com, we gathered 15 ratings published for MDT stock in the last month.The general sentiment of these ratings is bullish for MDT stock, with 11 positive ratings.
Is MDT a good stock to buy?
Date
Analyst / Broker
Previous rating
Current rating
2019-8-28
Needham & Company LLC
n/a
Buy
2019-8-21
Wells Fargo & Co
n/a
Outperform
2019-8-21
UBS Group
n/a
Buy
2019-8-21
Stifel Nicolaus
n/a
Hold
2019-8-21
Raymond James
n/a
Buy
2019-8-21
Raymond James
n/a
Outperform
2019-8-21
Northland Securities
n/a
Hold
2019-8-21
Morgan Stanley
n/a
Equal Weight
2019-8-21
BTIG Research
n/a
Buy
2019-8-21
BMO Capital Markets
n/a
Outperform
2019-8-21
BMO Capital Markets
n/a
Outperform
2019-8-21
Barclays
n/a
Overweight
2019-8-19
Deutsche Bank
n/a
Buy
2019-8-16
Royal Bank of Canada
n/a
Outperform
2019-8-14
Morgan Stanley
n/a
Equal Weight
Medtronic stock analysis
Daily outlook
Medtronic depreciated an unpleasant -0.36% and closed at $108.12.
Medtronic shares depreciated -0.36% to $108.12 on Oct 18th. On July, SMA100d and SMA200d crossed up triggering a rise of 12.19%. On Oct 9th MDT price bounced up over the SMA of 50 days demonstrating to be a significant support for this stock. On Sep 24th, MDT hit new all time highs, pushing higher previous ATH of $111.17 recorded on September 19th. New ATHs are usual entry points for many trading setups as there aren't higher resistences.
MDT stock chart (daily)
Weekly outlook
Medtronic shares grew 0.50% this week, ending at $108.12.
MDT marked an uptrend of rising tops and rising bottoms. Since its last top late September at $111.49, price slid and bounced up back from $105.00. Breaking down under $105.00 would cancel the current uptrend and it might test lower supports. Note that $111.49 might act as a resistance line. Not so far away is the last all-time high Medtronic marked late September. Since SMA20d and SMA40w crossed up late June, MDT price climbed $9.78 per share (9.95%). Since price and SMA40w lines crossed up late May, MDT climbed $21.31 (24.55%).
MDT stock chart (weekly)
Medtronic stock price history
Medtronic stock historical price chart
MDT stock reached all-time highs on September/24 with a price of $111.49.
Medtronic stock price target is $115.50
Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. You should not follow the analysts' MDT stock price predictions in the hope that they will be met as they may be wrong and not met. We have 15 price targets for Medtronic stock published in the last month:
MDT stock price predictions
Date
Analyst / Broker
Action
Previous target
Current target
Diff
2019-8-28
Needham & Company LLC
Reiterates
n/a
$133.00
-
2019-8-21
Wells Fargo & Co
Reiterates
$110.00
$120.00
9.1%
2019-8-21
UBS Group
Raises Target
$112.00
$122.00
8.9%
2019-8-21
Stifel Nicolaus
Reiterates
$95.00
$112.00
17.9%
2019-8-21
Raymond James
Reiterates
$105.00
$118.00
12.4%
2019-8-21
Raymond James
Raises Target
$105.00
$118.00
12.4%
2019-8-21
Northland Securities
Reiterates
n/a
$100.00
-
2019-8-21
Morgan Stanley
Raises Target
$105.00
$111.00
5.7%
2019-8-21
BTIG Research
Raises Target
n/a
$120.00
-
2019-8-21
BMO Capital Markets
Reiterates
$107.00
$118.00
10.3%
2019-8-21
BMO Capital Markets
Raises Target
$107.00
$118.00
10.3%
2019-8-21
Barclays
Raises Target
$110.00
$117.00
6.4%
2019-8-19
Deutsche Bank
Reiterates
$100.00
$111.00
11%
2019-8-16
Royal Bank of Canada
Raises Target
n/a
$110.00
-
2019-8-14
Morgan Stanley
Raises Target
$100.00
$105.00
5%
(in average)
$105.10
$115.50
10.0%
The price prediction for Medtronic stock is $115.50, moving in a range between $133.00 and $100.00. In average, analysts' outlook on MDT price forecast is positive, increasing the forecast by a 10.00% from previous estimations.
Financials and fundamental analysis
Earnings date and Earnings per Share
Medtronic reported slightly fine results for 2019-Q1 on February. Medtronic gained Earnings per Share (EPS) by 4.00%, beating experts estimates of $1.24. Medtronic posted $1.29.
MDT earnings date and EPS evolution
Quarter
Reporting date
Estimated EPS
Actual EPS
Surprise
2017-Q2
-
n/a
n/a
n/a
2017-Q3
-
n/a
n/a
n/a
2017-Q4
-
n/a
n/a
n/a
2018-Q1
2018-02-20
1.16
1.17
0.9%
2018-Q2
2018-05-24
1.38
1.42
2.9%
2018-Q3
2018-08-21
1.11
1.17
5.4%
2018-Q4
2018-11-20
1.14
1.22
7.0%
2019-Q1
2019-02-19
1.24
1.29
4.0%
2019-Q2
-
n/a
n/a
n/a
2019-Q3
-
n/a
n/a
n/a
Annual financial results
In 2018, Medtronic annual sales stayed constant a neutral 0.01% to $29,953.00 M USD from $29,950.00 marked in 2018.In the same way, its profit margin (compared to sales) remained stable to 10.36%, that is $3,104.00 million.To have an up to date view of the financial situation of Medtronic, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2019-Q1 that can be compared to 2018 fiscal year results. Annual Medtronic TTM sales up to January 2019 were $30,555.00 and earnings were $4,919.00 M dollars.When comparing this TTM figures with the last reported annuality, we can esteem Medtronic business evolution since April 2018: Annual turnover up to January, compared to lastest yearly report, gained a tiny 2.01%.Similarly, profit margin (net income/revenues) soared at 10.36%.
MDT annual Sales and Income evolution
Year
Sales
YoY
Income/(margin)
YoY
2014
$17,010 M
-
$3,070 M18.0%
-
2014
$17,010 M
0.00%
$3,070 M18.0%
0.00%
2015
$20,260 M
19.11%
$2,680 M13.2%
-12.70%
2015
$20,261 M
0.00%
$2,675 M13.2%
-0.19%
2016
$28,830 M
42.29%
$3,540 M12.3%
32.34%
2016
$28,833 M
0.01%
$3,538 M12.3%
-0.06%
2017
$29,710 M
3.04%
$4,030 M13.6%
13.91%
2017
$29,710 M
0.00%
$4,028 M13.6%
-0.05%
2018
$29,950 M
0.81%
$3,100 M10.4%
-23.04%
2018
$29,953 M
0.01%
$3,104 M10.4%
0.13%
TTM
$30,555 M
2.01%
$4,919 M16.1%
58.47%
Quarterly financial results
Medtronic reported $7,546.00 million in sales for 2019-Q1, a 0.87% up compared to previous quarter.Reported quarter income marked $1,269.00 million with a profit margin of 16.82%. Profit margin inched a 1.91% compared to previous quarter when profit margin was 14.90%.When comparing revenues to same quarter last year, Medtronic sales marked a slightly good growth and raised a 2.40%.Looking back to recent quarterly results, Medtronic posted 2 negative quarters in a row.
MDT quarterly Sales and Income evolution
Quarter
Sales1
QoQ2
Income1/(margin)
QoQ2
2017-Q2
$7,920 M
-
$1,160 M14.6%
-
2017-Q3
$7,390 M
-6.69%
$1,020 M13.8%
-12.07%
2017-Q4
$7,050 M
-4.60%
$2,017 M28.6%
97.75%
2018-Q1
$7,369 M
4.52%
$-1,389 M-18.8%
-168.86%
2018-Q2
$8,144 M
10.52%
$1,460 M17.9%
-205.11%
2018-Q3
$7,384 M
-9.33%
$1,075 M14.6%
-26.37%
2018-Q4
$7,481 M
1.31%
$1,115 M14.9%
3.72%
2019-Q1
$7,546 M
0.87%
$1,269 M16.8%
13.81%
Medtronic ownership
When you are planning to invest in shares of a company, it's worth to have a look its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Medtronic, 0.06% of all outstanding shares are owned by its staff.
Bearish positions for MDT stock account 0.00%, no big difference from last month.
For a better understanding, the following table shows ownership data compared to other related companies:
MDT
ABT
BAX
BSX
CNMD
Market cap
$144.9 B
$146.5 B
$44.9 B
$53.5 B
$2.8 B
Total shares
1,340.0 M
1,770.0 M
510.6 M
1,390.0 M
28.3 M
Float shares
1,340.0 M
1,750.0 M
509.6 M
1,390.0 M
27.6 M
- Institutional holdings (%)
84.2%
76.5%
88.2%
93.4%
97.5%
- Insider holdings (%)
0.1%
0.7%
0.1%
0.2%
1.8%
Shares in short selling
0.0%
0.0%
0.0%
0.0%
0.0%
Medtronic summary
Friday, October 18th, 2019
Open
$108.47
Close
$108.12
Day range
$107.96 - $108.91
Previous close
$108.51
Session gain
-0.36%
Average true range
$1.60
50d mov avg
$106.92
100d mov avg
$102.60
200d mov avg
$95.23
Daily pattern
Weekly pattern
lb03a
Medtronic performance
To measure stock performance is always good to benchmark with competitors or related stocks. We selected , Baxter International, Boston Scientific, CONMED, Edwards Lifesciences, Integra LifeSciences, , Owens & Minor, Stryker and Zimmer Biomet as the bechmarking frame for Medtronic stock.
Stock
3m
6m
12m
MDTMedtronic
7.81%
29.73%
17.61%
ABT
-4.99%
12.87%
24.51%
BAXBaxter Internatio...
6.15%
19.02%
28.04%
BSXBoston Scientific
-8.95%
9.57%
5.28%
CNMDCONMED
16.00%
23.41%
37.36%
EWEdwards Lifescien...
17.05%
28.32%
56.42%
IARTIntegra LifeScien...
14.81%
22.19%
-0.14%
JNJ
-1.27%
-5.81%
-5.62%
OMIOwens & Minor
170.45%
111.87%
-51.72%
SYKStryker
3.76%
20.05%
28.86%
ZBHZimmer Biomet
11.67%
15.12%
11.52%
Medtronic competitors
We picked a few stocks to conform a list of Medtronic competitors to check if you are interested in investing in MDT: